SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
26.68
+0.26 (0.98%)
At close: Mar 6, 2026, 4:00 PM EST
26.94
+0.26 (0.97%)
After-hours: Mar 6, 2026, 5:04 PM EST
SpyGlass Pharma Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for SpyGlass Pharma stock have an average target of 47, with a low estimate of 42 and a high estimate of 62. The average target predicts an increase of 76.16% from the current stock price of 26.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SpyGlass Pharma stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 |
|---|---|
| Strong Buy | 3 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +57.42% | Mar 3, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $42 | Buy | Initiates | $42 | +57.42% | Mar 3, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +132.38% | Mar 3, 2026 |
| Stifel | Stifel | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +57.42% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.